Pancreatic Cancer Research

ResearcherKyoto Prefectural University of MedicineActive in the last 2 years

Ryo Morimura

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5594-0943; OpenAlex author ID A5015703827. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
28
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 2 papers · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 3 papers

Papers 13

  1. Rising Pancreatic Cancer Incidence in Young Japanese Women and Increasing Distal Pancreatectomy in Older Adults: A Nationwide Claims-Based Analysis From 2016 t… First author DOI 10.1002/ags3.70178↗
  2. Mesenteric Versus Conventional Approach During Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma (MAPLE-PD trial): A Multicenter Randomized Controlled… Co-author DOI 10.1097/sla.0000000000006900↗
  3. [Resection of Borderline Resectable Pancreatic Cancer with Arterial Involvement Following a Marked Response to Neoadjuvant Chemotherapy-A Case Report]. Co-author PMID 42723240↗
  4. Cancer-Derived Small Extracellular Vesicles Affect Vascular Endothelial Cells and Promote Adhesiveness of Pancreatic Cancer Cells. Co-author DOI 10.1097/mpa.0000000000002346↗
  5. Roles of voltage‑gated potassium channels in the maintenance of pancreatic cancer stem cells. Co-author DOI 10.3892/ijo.2021.5256↗
  6. Photodynamic diagnosis of peritoneal metastasis in human pancreatic cancer using 5-aminolevulinic acid during staging laparoscopy. Co-author DOI 10.3892/ol.2018.8732↗
  7. Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer. Co-author DOI 10.1038/s41598-017-06137-8↗
  8. Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids. Co-author DOI 10.3748/wjg.v22.i25.5627↗
  9. Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer. Co-author DOI 10.1038/bjc.2015.366↗
  10. Optimal duration of the early and late recurrence of pancreatic cancer after pancreatectomy based on the difference in the prognosis. Co-author DOI 10.1016/j.pan.2014.09.006↗
  11. The clinical impact of the lymph node ratio as a prognostic factor after resection of pancreatic cancer. Co-author PMID 24778048↗
  12. Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer. Co-author DOI 10.1038/bjc.2012.546↗
  13. Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer. Co-author DOI 10.1038/bjc.2011.453↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Atsushi Shiozaki · 11 shared papers, 2011–2026 · strength 1.08
  2. Taisuke Imamura · 5 shared papers, 2015–2026 · strength 0.67
  3. Eigo Otsuji · 10 shared papers, 2011–2024 · strength 0.64
  4. Hidemasa Kubo · 3 shared papers, 2018–2026 · strength 0.60
  5. Masamitsu Kido · 1 shared paper, 2026 · strength 0.28
  6. Daisuke Ichikawa · 7 shared papers, 2011–2017 · strength 0.27
  7. Goshi Takayama · 1 shared paper, 2026 · strength 0.24
  8. Hideki Motobayashi · 1 shared paper, 2026 · strength 0.23
  9. Akimasa Nakao · 1 shared paper, 2026 · strength 0.23
  10. Sohei Satoi · 1 shared paper, 2026 · strength 0.23
  11. Masaaki Hidaka · 1 shared paper, 2026 · strength 0.23
  12. Keiko Kamei · 1 shared paper, 2026 · strength 0.23
  13. Yuji Kitahata · 1 shared paper, 2026 · strength 0.23
  14. Kenjiro Kimura · 1 shared paper, 2026 · strength 0.23
  15. Hiromitsu Hayashi · 1 shared paper, 2026 · strength 0.23
  16. Masafumi Nakamura · 1 shared paper, 2026 · strength 0.23
  17. Masayuki Sho · 1 shared paper, 2026 · strength 0.23
  18. Hiroki Yamaue · 1 shared paper, 2026 · strength 0.23
  19. Kenichiro Uemura · 1 shared paper, 2026 · strength 0.23
  20. Yuichi Nagakawa · 1 shared paper, 2026 · strength 0.23
  21. Yuko Mataki · 1 shared paper, 2026 · strength 0.23
  22. Seiko Hirono · 1 shared paper, 2026 · strength 0.23
  23. Hirotaka Furuke · 1 shared paper, 2024 · strength 0.18
  24. Jun Shibamoto · 1 shared paper, 2024 · strength 0.18
  25. Mahito Miyamae · 3 shared papers, 2015–2017 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.